Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Sigyn Therapeutics Inc
(OP:
SIGY
)
1.710
UNCHANGED
Last Price
Updated: 11:39 AM EST, Dec 16, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.710
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
1.710
Today's Range
1.710 - 1.710
52wk Range
1.400 - 5.000
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Sigyn CEO Note: First-In-Industry Attributes of CardioDialysisTM to Treat Cardiovascular Disease
December 11, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Sigyn CEO Note: First-In-Industry Attributes of CardioDialysisTM to Treat Cardiovascular Disease
December 11, 2025
Via
TheNewswire.com
Performance
YTD
-46.6%
-46.6%
1 Month
-14.5%
-14.5%
3 Month
-54.4%
-54.4%
6 Month
-38.9%
-38.9%
1 Year
-46.6%
-46.6%
More News
Read More
Sigyn CEO Note: Nature Publication Reinforces Rationale for CardioDialysisTM to Address Cardiovascular Disease in Dialysis Patients
December 03, 2025
Via
NewMediaWire
Sigyn CEO Note: Nature Publication Reinforces Rationale for CardioDialysisTM to Address Cardiovascular Disease in Dialysis Patients
December 03, 2025
Via
TheNewswire.com
Sigyn CardioDialysis(TM) Featured on the Big Biz Show
November 18, 2025
Via
NewMediaWire
Topics
Death
Sigyn Therapeutics Announces Cardiovascular Disease Study
September 03, 2025
Via
TheNewswire.com
Topics
Death
Sigyn CardioDialysis(TM) Featured on the Big Biz Show
November 18, 2025
Via
TheNewswire.com
Topics
Death
Sigyn Therapeutics Reports Third Quarter Financial Results and Subsequent Introduction of CardioDialysis(TM)
November 14, 2025
Via
TheNewswire.com
Topics
Intellectual Property
Sigyn Therapeutics Reports Third Quarter Financial Results and Subsequent Introduction of CardioDialysis(TM)
November 14, 2025
Via
NewMediaWire
Topics
Intellectual Property
Sigyn Therapeutics Releases Shareholder Letter to Introduce CardioDialysis(TM)
November 06, 2025
Via
NewMediaWire
Topics
Intellectual Property
Sigyn Therapeutics Releases Shareholder Letter to Introduce CardioDialysis(TM)
November 06, 2025
Via
TheNewswire.com
Topics
Intellectual Property
Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing
September 18, 2025
From
Virtual Investor Conferences
Via
GlobeNewswire
Sigyn Therapeutics to Present at the Life Sciences Virtual Investor Forum on September 18th
September 16, 2025
From
Virtual Investor Conferences
Via
GlobeNewswire
Life Science Virtual Investor Forum Agenda Announced for September 18th
September 16, 2025
From
Virtual Investor Conferences
Via
GlobeNewswire
Sigyn Therapeutics Appoints Dr. Christoph Zaba to Its Scientific Advisory Board
September 11, 2025
Via
NewMediaWire
Sigyn Therapeutics Appoints Dr. Christoph Zaba to Its Scientific Advisory Board
September 11, 2025
Via
TheNewswire.com
Sigyn Therapeutics Announces Cardiovascular Disease Study
September 03, 2025
Via
NewMediaWire
Topics
Death
RETRANSMISSION: Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
July 01, 2025
Via
ACCESS Newswire
Goldman Small Cap Research Publishes New Research Report on Sigyn Therapeutics Inc.
July 01, 2025
Via
ACCESS Newswire
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making
March 12, 2025
Via
NewMediaWire
Topics
Death
Sigyn CEO Note: An Emerging New Industry, 15 Years in the Making
March 12, 2025
Via
TheNewswire.com
Topics
Death
Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses
March 05, 2025
Via
NewMediaWire
Sigyn CEO Note: Combating the Rising Threat of New Pandemic Viruses
March 05, 2025
Via
TheNewswire.com
Sigyn Therapeutics to be Featured in Fireside Chat With Zacks Healthcare Analyst
February 25, 2025
Via
NewMediaWire
Sigyn Therapeutics to be Featured in Fireside Chat With Zacks Healthcare Analyst
February 25, 2025
Via
TheNewswire.com
Frequently Asked Questions
Is Sigyn Therapeutics Inc publicly traded?
Yes, Sigyn Therapeutics Inc is publicly traded.
What exchange does Sigyn Therapeutics Inc trade on?
Sigyn Therapeutics Inc trades on the OTC Traded
What is the ticker symbol for Sigyn Therapeutics Inc?
The ticker symbol for Sigyn Therapeutics Inc is SIGY on the OTC Traded
What is the current price of Sigyn Therapeutics Inc?
The current price of Sigyn Therapeutics Inc is 1.710
When was Sigyn Therapeutics Inc last traded?
The last trade of Sigyn Therapeutics Inc was at 12/16/25 11:39 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.